As part of the treatment strategy for patients with inflammatory bowel disease (IBD), inhibitors of tumor necrosis factor alpha (TNFα) have been shown to be effective in reducing their symptoms associated with IBD. The gene discussed is TNF; the disease is inflammatory bowel disease.